These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 3905673)

  • 21. Association of very high blood levels of cyclosporin metabolites with clinical complications after liver transplantation.
    Kohlhaw K; Wonigeit K; Schäfer O; Ringe B; Bunzendahl H; Pichlmayr R
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2232-3. PubMed ID: 2652722
    [No Abstract]   [Full Text] [Related]  

  • 22. Factors predictive of cyclosporine-induced nephrotoxicity: the role of cyclosporine blood levels.
    Bach JF; Feutren G; Noel LH; Hannedouche T; Landais P; Timsit J; Boitard C; Bougnères P; Boitard C; Grünfeld JP
    Transplant Proc; 1990 Jun; 22(3):1296-8. PubMed ID: 2349690
    [No Abstract]   [Full Text] [Related]  

  • 23. Interaction of cyclosporin and calcium antagonists.
    Wagner K; Philipp T; Heinemeyer G; Brockmüller F; Roots I; Neumayer HH
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1453-6. PubMed ID: 2652465
    [No Abstract]   [Full Text] [Related]  

  • 24. [Cyclosporin A. Bright prospects for organ transplantation?].
    Dieperink H; Frandsen NE; Kemp E
    Ugeskr Laeger; 1983 Sep; 145(36):2749-52. PubMed ID: 6356544
    [No Abstract]   [Full Text] [Related]  

  • 25. Interaction between phenytoin and cyclosporine following organ transplantation.
    Keown PA; Laupacis A; Carruthers G; Stawecki M; Koegler J; McKenzie FN; Wall W; Stiller CR
    Transplantation; 1984 Sep; 38(3):304-6. PubMed ID: 6474556
    [No Abstract]   [Full Text] [Related]  

  • 26. Cyclosporin A efficacy and toxicity in organ transplantation with special focus on cadaveric renal transplantation.
    Lesne M; Squifflet JP; Wallemacq P; Lenain F; Alexandre G
    Chemioterapia; 1985 Oct; 4(5):400-5. PubMed ID: 3907864
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cyclosporin-induced nephrotoxicity].
    Heering P; Grabensee B
    Dtsch Med Wochenschr; 1988 May; 113(20):833-4. PubMed ID: 3286182
    [No Abstract]   [Full Text] [Related]  

  • 28. The effects and side effects of cyclosporine: relationship to drug pharmacokinetics.
    Keown PA; Stiller CR; Laupacis AL; Howson W; Coles R; Stawecki M; Koegler J; Carruthers G; McKenzie N; Sinclair NR
    Transplant Proc; 1982 Dec; 14(4):659-61. PubMed ID: 6762722
    [No Abstract]   [Full Text] [Related]  

  • 29. Some experimental and clinical studies of Cyclosporin A in renal transplantation.
    Morris PJ
    Transplant Proc; 1982 Sep; 14(3):525-8. PubMed ID: 6758238
    [No Abstract]   [Full Text] [Related]  

  • 30. [Cyclosporin: experimental studies and clinical use in organ transplants].
    Araujo JL; Towpik E; Kupiec-Weglinski JW; Tilney NL
    Rev Invest Clin; 1984; 36(4):367-76. PubMed ID: 6396785
    [No Abstract]   [Full Text] [Related]  

  • 31. Is cyclosporine-associated nephrotoxicity progressive?
    Vanrenterghem Y; Waer M; Roels L; Lerut T; Michielsen P
    Transplant Proc; 1987 Oct; 19(5):4031-2. PubMed ID: 3313992
    [No Abstract]   [Full Text] [Related]  

  • 32. Is cyclosporine administration in twice daily dose advantageous?
    Savoldi S; Sandrini S; Scolari F; Brunori G; Prati E; Camerini C; Scaini P; Cristinelli L; Maiorca R
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1720-2. PubMed ID: 3274414
    [No Abstract]   [Full Text] [Related]  

  • 33. [Antibacterial chemotherapy in renal failure].
    Briedigkeit H
    Z Urol Nephrol; 1983 May; 76(5):349-52. PubMed ID: 6880421
    [No Abstract]   [Full Text] [Related]  

  • 34. [Cyclosporin A: a new immunosuppressive agent in renal transplantation].
    Martín RS; Thiel G; Brunner F
    Medicina (B Aires); 1985; 45(6):675-86. PubMed ID: 3916124
    [No Abstract]   [Full Text] [Related]  

  • 35. [Liver transplantation: current status and perspectives].
    Pichlmayr R
    Z Gastroenterol Verh; 1986 Apr; 21():182-9. PubMed ID: 2422835
    [No Abstract]   [Full Text] [Related]  

  • 36. The effects of liver and renal dysfunction on the pharmacokinetics of sedatives and analgesics in the critically ill patient.
    Yogaratnam D; Miller MA; Smith BS
    Crit Care Nurs Clin North Am; 2005 Sep; 17(3):245-50. PubMed ID: 16115532
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclosporine: preliminary experience in 79 patients with renal transplants.
    Tellis VA; Matas AJ; Glichlick D; Quinn T; Soberman R; Weiss R; Veith FJ
    N Y State J Med; 1985 Sep; 85(9):531-4. PubMed ID: 3903567
    [No Abstract]   [Full Text] [Related]  

  • 38. The correlation of cyclosporine serum and whole blood concentrations with toxicity and efficacy after human marrow transplantation.
    Britton K; Atkinson K; Downs K; Biggs J
    Transplant Proc; 1985 Apr; 17(2):1667-70. PubMed ID: 3885501
    [No Abstract]   [Full Text] [Related]  

  • 39. [Cyclosporin: new acquisition in transplant immunosuppression].
    Stabile Neto C
    AMB Rev Assoc Med Bras; 1987; 33(9-10):201-4. PubMed ID: 3333296
    [No Abstract]   [Full Text] [Related]  

  • 40. Cyclosporine immunosuppression.
    Canafax DM; Ascher NL
    Clin Pharm; 1983; 2(6):515-24. PubMed ID: 6360494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.